Cerus Corp. Stock
Price
Target price
€1.69
€1.69
-4.510%
-0.079
-4.510%
€3.82
02.01.26 / Tradegate
WKN: 905249 / Symbol: CERS / Name: Cerus Corp / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cerus Corp. Stock
Cerus Corp. took a tumble today and lost -€0.079 (-4.510%).
The community is currently still undecided about Cerus Corp. with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 3 € shows a very positive potential of 77.94% compared to the current price of 1.69 € for Cerus Corp..
Pros and Cons of Cerus Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cerus Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cerus Corp. | -4.510% | -6.333% | 4.526% | 12.776% | -3.767% | -49.354% | -71.179% |
| Lemaitre Vascular Inc | -2.840% | -4.861% | -4.861% | -23.464% | -2.837% | - | - |
| Lantheus Holdings Inc | 0.380% | 1.700% | 13.974% | -33.665% | 0.385% | 21.139% | - |
| Natera Inc | -1.520% | -2.500% | -4.412% | 24.204% | -1.015% | 432.787% | - |
Comments
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its price target lowered by analysts at Stifel Nicolaus from $6.00 to $3.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its price target raised by analysts at Cantor Fitzgerald from $3.00 to $4.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat